{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:48:03Z","timestamp":1793119683290,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05321-z","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:26:35Z","timestamp":1748528795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fluconazole-induced drug rash with eosinophilia and systemic symptoms syndrome: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1932-7834","authenticated-orcid":false,"given":"Stanley","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"5321_CR1","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1056\/NEJMra2204547","volume":"391","author":"D Kroshinsky","year":"2024","unstructured":"Kroshinsky D, Cardones ARG, Blumenthal KG. Drug reaction with eosinophilia and systemic symptoms. NEJM. 2024;391:2242\u201354. https:\/\/doi.org\/10.1056\/NEJMra2204547.","journal-title":"NEJM"},{"issue":"5","key":"5321_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","volume":"90","author":"BM Wei","year":"2024","unstructured":"Wei BM, Fox LP, Kaffenberger BH, et al. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: part I Epidemiology, pathogenesis, clinicopathological features, and prognosis. J Am Acad Dermatol. 2024;90(5):885\u2013908. https:\/\/doi.org\/10.1016\/j.jaad.2023.02.072.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"5321_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaad.2023.02.073","volume":"90","author":"BM Wei","year":"2024","unstructured":"Wei BM, Fox LP, Kaffenberger BH, et al. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: part II diagnosis and management. J Am Acad Dermatol. 2024;90(5):911\u201326. https:\/\/doi.org\/10.1016\/j.jaad.2023.02.073.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5321_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","volume":"68","author":"T Shiohara","year":"2019","unstructured":"Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Allergol Int. 2019;68(3):301\u20138. https:\/\/doi.org\/10.1016\/j.alit.2019.03.006.","journal-title":"Allergol Int"},{"issue":"4","key":"5321_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","volume":"15","author":"H Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250\u20137.","journal-title":"Semin Cutan Med Surg"},{"key":"5321_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609\u201311. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07704.x.","journal-title":"Br J Dermatol"},{"issue":"5","key":"5321_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction: results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071\u201380. https:\/\/doi.org\/10.1111\/bjd.12501.","journal-title":"Br J Dermatol"},{"issue":"5","key":"5321_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","volume":"156","author":"T Shiohara","year":"2007","unstructured":"Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156(5):1083\u20134. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07807.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"5321_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1872213X13666190919162414","volume":"13","author":"G Calogiuri","year":"2019","unstructured":"Calogiuri G, Garvey LH, Nettis E, et al. Skin allergy to azole antifungal agents for systemic use: a review of the literature. Recent Pat Inflamm Allergy Drug Discov. 2019;13(2):144\u201357. https:\/\/doi.org\/10.2174\/1872213X13666190919162414.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"5321_CR10","first-page":"A1357","volume":"209","author":"N Sarantopoulos","year":"2024","unstructured":"Sarantopoulos N, Wiltchik E, Thakkar V, Klein W. Fluconazole associated DRESS syndrome in patient with coccidioidomycosis pneumonia. Am J Respir Crit Care Med. 2024;209:A1357.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"5321_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/cid\/ciac798","volume":"76","author":"JL Waldron","year":"2023","unstructured":"Waldron JL, James F, Vogrin S, et al. A shorter time to drug reaction with eosinophilia and systemic symptoms (DRESS): redefining beta-lactam-associated DRESS. Clin Infect Dis. 2023;76(4):772\u20134. https:\/\/doi.org\/10.1093\/cid\/ciac798.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"5321_CR12","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/jcm10184287","volume":"10","author":"D Jevtic","year":"2021","unstructured":"Jevtic D, Dumic I, Nordin T, et al. Less known gastrointestinal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of the literature. J Clin Med. 2021;10(18):4287. https:\/\/doi.org\/10.3390\/jcm10184287.","journal-title":"J Clin Med"},{"issue":"2","key":"5321_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","volume":"155","author":"Y Kano","year":"2006","unstructured":"Kano Y, Hiraharas K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol. 2006;155(2):301\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07238.x.","journal-title":"Br J Dermatol"},{"issue":"9","key":"5321_CR14","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1016\/j.jaip.2023.05.017","volume":"11","author":"C Sibbald","year":"2023","unstructured":"Sibbald C, Shear NH, Verstegen RHJ. Flaws and limitations of classification criteria for drug reaction with eosinophilia and systemic symptoms. J Allergy Clin Immunol Pract. 2023;11(9):2693\u20136. https:\/\/doi.org\/10.1016\/j.jaip.2023.05.017.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"5321_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/idoj.idoj_196_21","volume":"13","author":"S Sasidharanpillai","year":"2022","unstructured":"Sasidharanpillai S, Ajithkumar K, Jishna P, et al. RegiSCAR DRESS (Drug reaction with eosinophilia and systemic symptoms) validation scoring system and Japanese Consensus Group criteria for atypical drug-induced hypersensitivity syndrome (DiHS): a comparative analysis. Indian Dermatol Online J. 2022;13(1):40\u20135. https:\/\/doi.org\/10.4103\/idoj.idoj_196_21.","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"5321_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.18176\/jiaci.0480","volume":"30","author":"R Caba\u00f1as","year":"2020","unstructured":"Caba\u00f1as R, Ram\u00edrez E, Sendagorta E, et al. Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome. J Investig Allergol Clin Immunol. 2020;30(4):229\u201353. https:\/\/doi.org\/10.18176\/jiaci.0480.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"7","key":"5321_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588\u201397. https:\/\/doi.org\/10.1016\/j.amjmed.2011.01.017.","journal-title":"Am J Med"},{"issue":"8","key":"5321_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","volume":"139","author":"WJ Pichler","year":"2003","unstructured":"Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139(8):683\u201393. https:\/\/doi.org\/10.7326\/0003-4819-139-8-200310210-00012.","journal-title":"Ann Intern Med"},{"key":"5321_CR19","volume-title":"Type I hypersensitivity reaction","author":"M Abbas","year":"2023","unstructured":"Abbas M, Moussa M, Akel H. Type I hypersensitivity reaction. Treasure Island (FL): StatPearls Publishing; 2023."},{"issue":"3","key":"5321_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.annder.2021.02.002","volume":"148","author":"C Brin","year":"2021","unstructured":"Brin C, Bernigaud C, Hua C, et al. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): a monocenter retrospective study of 20 cases. Ann Dermatol Venereol. 2021;148(3):168\u201371. https:\/\/doi.org\/10.1016\/j.annder.2021.02.002.","journal-title":"Ann Dermatol Venereol"},{"issue":"6","key":"5321_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1468-3083.2012.04547.x","volume":"27","author":"H Uhara","year":"2013","unstructured":"Uhara H, Saiki M, Kawachi S, Ashida A, Oguchi S, Okuyama R. Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids. J Eur Acad Dermatol Venereol. 2013;27(6):722\u20136. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04547.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"5321_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","volume":"72","author":"E Funck-Brentano","year":"2015","unstructured":"Funck-Brentano E, Duong TA, Bouvresse S, et al. Therapeutic management of DRESS: a retrospective study of 38 cases. J Am Acad Dermatol. 2015;72(2):246\u201352. https:\/\/doi.org\/10.1016\/j.jaad.2014.10.032.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"5321_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","volume":"148","author":"P Joly","year":"2012","unstructured":"Joly P, Janela B, Tetart F, et al. Poor benefit\/risk balance of intravenous immunoglobulins in DRESS. Arch Dermatol. 2012;148(4):543\u20134. https:\/\/doi.org\/10.1001\/archderm.148.4.dlt120002-c.","journal-title":"Arch Dermatol"},{"issue":"3","key":"5321_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","volume":"80","author":"Y Mizukawa","year":"2019","unstructured":"Mizukawa Y, Hirahara K, Kano Y, Shiohara T. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J Am Acad Dermatol. 2019;80(3):670-678.e2. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.052.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"5321_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2006.01295.x","volume":"49","author":"H Hof","year":"2006","unstructured":"Hof H. A new, broad-spectrum azole antifungal: posaconazole\u2013mechanisms of action and resistance, spectrum of activity. Mycoses. 2006;49(Suppl 1):2\u20136. https:\/\/doi.org\/10.1111\/j.1439-0507.2006.01295.x.","journal-title":"Mycoses"},{"issue":"5","key":"5321_CR26","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.anai.2019.08.095","volume":"123","author":"A Patel","year":"2019","unstructured":"Patel A, Agnihotri N, Grammer L. M017 triazole drug allergy: successful toleration of posaconazole after reactions to fluconazole and isavuconazole. Ann Allergy Asthma Immunol. 2019;123(5):S69. https:\/\/doi.org\/10.1016\/j.anai.2019.08.095.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"5321_CR27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/jcpt.12417","volume":"41","author":"D Benjamin Lash","year":"2016","unstructured":"Benjamin Lash D, Jolliff J, Munoz A, Heidari A. Cross-reactivity between voriconazole, fluconazole and itraconazole. J Clin Pharm Ther. 2016;41(5):566\u20137. https:\/\/doi.org\/10.1111\/jcpt.12417.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"5321_CR28","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1128\/AAC.01500-08","volume":"53","author":"A Pinto","year":"2009","unstructured":"Pinto A, Chan RC. Lack of allergic cross-reactivity between fluconazole and voriconazole. Antimicrob Agents Chemother. 2009;53(4):1715\u20136. https:\/\/doi.org\/10.1128\/AAC.01500-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5321_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/DER.0000000000000451","volume":"30","author":"L Schneller-Pavelescu","year":"2019","unstructured":"Schneller-Pavelescu L, Ochando-Ibern\u00f3n G, Vergara-de Caso E, Silvestre-Salvador JF. Herpes simplex-like fixed drug eruption induced by fluconazole without cross-reactivity to itraconazole. Dermatitis. 2019;30(2):174\u20135. https:\/\/doi.org\/10.1097\/DER.0000000000000451.","journal-title":"Dermatitis"},{"issue":"2","key":"5321_CR30","first-page":"255","volume":"20","author":"M Makris","year":"2021","unstructured":"Makris M, Fokoloros C, Syrmali A, Tsakiraki Z, Damaskou V, Papadavid E. Generalized bullous fixed drug eruption to fluconazole with positive patch testing and confirmed tolerance to itraconazole. Iran J Allergy Asthma Immunol. 2021;20(2):255\u20139.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"5321_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/s0091-6749(96)70136-7","volume":"98","author":"TJ Craig","year":"1996","unstructured":"Craig TJ, Peralta F, Boggavarapu J. Desensitization for fluconazole hypersensitivity. J Allergy Clin Immunol. 1996;98(4):845\u20136. https:\/\/doi.org\/10.1016\/s0091-6749(96)70136-7.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"5321_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.mayocp.2016.03.006","volume":"91","author":"TJ Bommersbach","year":"2016","unstructured":"Bommersbach TJ, Lapid MI, Leung JG, Cunningham JL, Rummans TA, Kung S. Management of psychotropic drug-induced dress syndrome: a systematic review. Mayo Clin Proc. 2016;91(6):787\u2013801. https:\/\/doi.org\/10.1016\/j.mayocp.2016.03.006.","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05321-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05321-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05321-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:26:36Z","timestamp":1748528796000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05321-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5321"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05321-z","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the Institutional Review Board (including ethical approval) at Kern Medical Center, Bakersfield, CA, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}